22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will present and meet with investors at the Virtual Fall Investor Summit. The conference is being held virtually November 16 -18, 2020.

22nd Century is scheduled to present on Tuesday, November 17, 2020 at 4:30 p.m. ET. The live webcast and presentation will be accessible in the Investors section of 22nd Century’s website under Events. An archived replay of the webcast will be available shortly after the live event.

Please visit https://investorsummitgroup.com/ to register for the conference and schedule one-on-one meeting with 22nd Century.

About 22nd Century Group, Inc.

22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking through the Company’s proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The Company’s primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury and on LinkedIn.

Investor Relations & Media Contact:Mei KuoDirector, Communications & Investor Relations22nd Century Group, Inc.(716) 300-1221mkuo@xxiicentury.com 

22nd Century (AMEX:XXII)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more 22nd Century Charts.
22nd Century (AMEX:XXII)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more 22nd Century Charts.